Clinical Trial Details

EORTC-62991-22998-STBSG-ROG

Back to Clinical Trials Database

Phase II pilot study of moderate dose radiotherapy for inoperable aggressive fibromatosis

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 13-Nov-2001
Date Step1 close: 02-Apr-2008
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 40
Treatment Radiotherapy
Study Staff
Type of cancer Soft Tissue and Bone Sarcoma
Participating groups EORTC Radiation Oncology Group
EORTC Soft Tissue and Bone Sarcoma Group
Recruiting centers Centre Leon Berard (Lyon, France)
Hopital de La Timone (APHM) (MARSEILLE CEDEX 5, France)
Instituut Verbeeten (Tilburg, Netherlands)
Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom)
Royal Marsden Hospital - Sutton, Surrey (Surrey, United Kingdom)
Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital (Sheffield, United Kingdom)
The Christie NHS Foundation Trust (Manchester, United Kingdom)
UHB-Queen Elizabeth Medical Centre (Birmingham, United Kingdom)
Universitaetsklinikum Tuebingen-Uni Kliniken Berg (Tuebingen, Germany)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
Centers to be activated Amsterdam UMC - locatie VUMC (Amsterdam, Netherlands)
Gustave Roussy (VILLEJUIF CEDEX, France)
Herlev Hospital - University Copenhagen (Herlev, Denmark)
Kliniken Der Stadt Ludwigshafen Am Rhein (Ludwigshafen Am Rhein, Germany)
Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany)
NHS Greater Glasgow and Clyde - Western Infirmary (Glasgow, United Kingdom)
Royal Marsden Hospital - Chelsea, London (London, United Kingdom)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Universitaetsklinik Dusseldorf (Duesseldorf, Germany)
Universitair Ziekenhuis Brussel (Brussels, Belgium)
Protocol summary http://clinicaltrials.gov/study/NCT00030680
NCT number NCT00030680
Financial Support EORTC HQ